Papers/PMID:26161708
Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis.
Archives of Iranian medicine2015The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
all-trans-retinol — no detected effect on expanded Disability Status Scale (EDSS)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“There were no significant differences between the "Mean ± SD" of EDSS changes in the treated (0.07 ± 0.23) and placebo (0.08 ± 0.23) groups (P = 0.73).”
Quoted verbatim from Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis.. - Study
- RCT
- Duration
- 12 months
- Dose
- retinyl palmitate 25000 IU/d for six months then 10000 IU/d for six months
- Population
- Patients with relapsing-remitting multiple sclerosis in a 1-year placebo-controlled trial
Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis.2015PMID:26161708Permalink